Crohn Disease Clinical Trials in New York, New York
11 recruitingNew York, New York
Showing 1–11 of 11 trials
Recruiting
Phase 1
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 3
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Janssen Research & Development, LLC460 enrolled5 locationsNCT07577843
Recruiting
Phase 2Phase 3
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Janssen Research & Development, LLC1,092 enrolled363 locationsNCT07196722
Recruiting
Phase 3
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Janssen Research & Development, LLC530 enrolled30 locationsNCT07499232
Recruiting
Phase 2
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
Crohn Disease (CD)
Washington University School of Medicine60 enrolled3 locationsNCT06976853
Recruiting
Phase 4
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Crohn Disease
Connecticut Children's Medical Center900 enrolled26 locationsNCT05781152
Recruiting
Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Crohn DiseaseColitis Ulcerative
Merck Sharp & Dohme LLC1,380 enrolled37 locationsNCT06651281
Recruiting
Phase 2
Standardized Microbiota Transplant Therapy in Crohn's Disease
Crohn Disease
University of Minnesota120 enrolled2 locationsNCT06631586
Recruiting
Phase 1Phase 2
Low Dose IL-2 for the Treatment of Crohn's Disease
Crohn Disease
Boston Children's Hospital30 enrolled3 locationsNCT04263831
Recruiting
Phase 2
Autologous Stem Cell Transplant for Crohn's Disease
Crohn Disease
Aaron Etra50 enrolled1 locationNCT03219359
Recruiting
Not Applicable
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Crohn DiseaseUlcerative Colitis
University of California, San Diego250 enrolled22 locationsNCT05230173